Philadelphia FIGHT (FIGHT) was founded as the Community-Based Research Initiative on AIDS as a partnership of individuals living with HIV/AIDS and clinicians who joined together to improve the lives of people living with the disease by testing potential treatments for HIV/AIDS and its complications. Today, clinicians at FIGHT continue to be involved in a number of studies.
What is a clinical trial?
A clinical trial is a controlled experiment in which people take medication for a specified time to determine its effectiveness and safety. Information gathered from clinical trials help create future treatments. Clinical trials are currently the most effective way to help people who have exhausted all proven therapies and to develop new and better treatments for people living with HIV/AIDS.
Who can enroll in a trial?
Each clinical trial has specific requirements; anyone meeting those requirements may be eligible to enroll in a trial. FIGHT clinical trials are free and participation is voluntary. Before participating in a study, patients go through a consenting process, which explains all the risks and benefits of that particular study. Participants may withdraw from clinical trials at any time without affecting access to their health care.
Click the link to view ongoing trials conducted at Philadelphia FIGHT Community Health Centers.
If you are interested in participating in clinical trials, please contact the research staff of Philadelphia FIGHT at 215-525-8695.
Thinking of conducting research at FIGHT?
If you would like to collaborate with a FIGHT investigator or conduct a research trial at FIGHT, please fill out the Philadelphia FIGHT Community Health Centers Research Conduct Proposal Form and return it to email@example.com. If you would like to recruit for an ongoing research trial from the FIGHT client-base, please forward your IRB approved advertisements to Linden along with a brief description of your research.
2019 HIV Prevention and Education Summit Call For Abstracts!
We are inviting you to participate in a unique opportunity to have your research presented to a wide, varied, and captivated audience. We would like to personally invite you to submit your research poster abstract for the HIV Prevention and Education Summit. The Summit provides the latest information about research, evidence-based HIV prevention, outreach strategies, and best practices in targeting and connecting to care the most at-risk groups in Philadelphia.
The general abstract submission deadline for the 2019 HIV Prevention and Education Summit is Friday, April 26th, 5:00 PM.
To submit your abstract for consideration, please complete the submission form and return to Linden Lalley-Chareczko, Research Program Director for Philadelphia FIGHT Community Health Centers, via email firstname.lastname@example.org.
Linden Lalley-Chareczko, Research Program Director, recently represented FIGHT and the Research Department in Atlanta at the 2019 National HIV Prevention Conference. FIGHT was fortunate to present original research demonstrating the utility of a urine test to detect tenofovir in samples collected from patients taking tenofovir alafenamide (Descovy™)